LC/MS/MS is a powerful tool for the study of metabolic disorders.As we already known, the simultaneous analysis of amino acids and acylcarnitines panels can provide information on nearly 40 metabolic disorders such as phenylketonuria (PKU). A simple flow-injection analysis can give results in 2 minutes with minimal sample preparation.
In recent years, researchers have extended the use of LC/MS/MS to include the Very Long Chain Fatty Acids for characterizing the Peroxisomal Disorders (PKU) and other clinically related biomarkers.
Based on combined proteomics and metabolomics profiling strategy and the biochemistry, cell biology, molecular biology knowledge, we systematically dedicated in research on human disease, elucidating the mechanism, detecting the corresponding biomarker and molecular target for infertility, meanwhile providing data for clinical diagnosis and intervention.
For Pharma and Biopharma customers in the discovery and development pipelines, we offer an innovative set of mass spectrometry, software and validation solutions to meet the demands of modern therapeutic discovery and development. With these innovations, we can help scientists to make confident decisions faster, enable them to move candidates through the pipeline, resulting in more efficacious, safer therapeutics.